Skye Bioscience Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio1.26-15.76-4.924.2223.79
Price/Tangible Book1.264.2223.79
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-0.80%-13.64%-2.70%-13.14%
Return on Assets (ROA)-0.45%-0.80%-1.21%-0.78%-1.68%
Return on Invested Capital (ROIC)-42.57%
Return on Capital Employed (ROCE)-0.44%6.90%6.09%-1.32%-3.34%
Leverage & Solvency Ratios
Debt/Equity0.01-2.17-0.660.363.32
Liquidity Ratios
Current Ratio16.320.840.742.463.38
Quick Ratio15.770.140.122.303.14
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-0.31%-1.12%-1.32%-0.34%-0.61%
FCF Yield-0.31%-0.42%-0.87%-0.27%-0.57%
Buyback Yield-4.21%-2.15%-0.37%-0.76%-0.36%